Clinical Trial Results

Showing: All studies [change]
Condition: Cancer Location: Cedar Rapids, Iowa 25 trials found
New Search
Filter
Trial Phase
Study Type
Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin
PHASE3INTERVENTIONAL Beverly Hills, California +4 more
RECRUITING
Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer
PHASE3INTERVENTIONAL Fayetteville, Arkansas +4 more
RECRUITING
Breast Cancer PSMA PET
EARLY_PHASE1INTERVENTIONAL Iowa City, Iowa
RECRUITING
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
PHASE1INTERVENTIONAL Springdale, Arkansas +4 more
RECRUITING
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
N/AOBSERVATIONAL Los Angeles, California +4 more
RECRUITING
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
PHASE1INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer
PHASE1INTERVENTIONAL Iowa City, Iowa +4 more
RECRUITING
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
PHASE3INTERVENTIONAL Homewood, Alabama +4 more
RECRUITING
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
PHASE1, PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients
PHASE1, PHASE2INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
Using Xe MRI to Guide Radiation Therapy for Lung Cancer
PHASE2INTERVENTIONAL Iowa City, Iowa
RECRUITING
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
PHASE1INTERVENTIONAL Iowa City, Iowa +4 more
RECRUITING
A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
PHASE2INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type